MATA NATHAN L. (Chief Scientific Officer) sold 6.4% of their position (1K shares) of BELITE BIO, INC on the open market
Open‑market sale worth $160.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
American depositary share
Shares
−216.00
Price / share
$158.28
Trade value
$34.19K
% of position
American depositary share
Shares
−219.00
Price / share
$159.81
Trade value
$35K
% of position
American depositary share
Shares
−201.00
Price / share
$160.35
Trade value
$32.23K
% of position
American depositary share
Shares
−240.00
Price / share
$161.61
Trade value
$38.79K
% of position
American depositary share
Shares
−76.00
Price / share
$162.26
Trade value
$12.33K
% of position
American depositary share
Shares
−36.00
Price / share
$163.21
Trade value
$5.88K
% of position
American depositary share
Shares
−12.00
Price / share
$164.12
Trade value
$1.97K
% of position
Net shares
−1K
Net value
-$160.38K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| American depositary share Direct | 4/16/2026 | S · Sale | −216.00 | $158.28 | $34.19K | 1.4% | 15.67K | 15.45K |
| American depositary share Direct | 4/16/2026 | S · Sale | −219.00 | $159.81 | $35K | 1.4% | 15.45K | 15.23K |
| American depositary share Direct | 4/16/2026 | S · Sale | −201.00 | $160.35 | $32.23K | 1.3% | 15.23K | 15.03K |
| American depositary share Direct | 4/16/2026 | S · Sale | −240.00 | $161.61 | $38.79K | 1.6% | 15.03K | 14.79K |
| American depositary share Direct | 4/16/2026 | S · Sale | −76.00 | $162.26 | $12.33K | 0.5% | 14.79K | 14.71K |
| American depositary share Direct | 4/16/2026 | S · Sale | −36.00 | $163.21 | $5.88K | 0.2% | 14.71K | 14.68K |
| American depositary share Direct | 4/16/2026 | S · Sale | −12.00 | $164.12 | $1.97K | 0.1% | 14.68K | 14.67K |
| Total | −1K | -$160.38K | ||||||